Florida Cancer Specialists & Research Institute

Sarasota, Florida 34232

2 studies enrolling now · 13 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumors, Appendiceal Adenocarcinoma, Bile Duct Cancer, Bladder Cancer, Breast Cancer, Breast Neoplasm Malignant Primary, Cervical Cancer, Cholangiocarcinoma, Colo-rectal Cancer, Colorectal Cancer, Colorectal Carcinoma

Studies at this site

• A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer — Recruiting now
• A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors — Recruiting now
• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors — Completed
• QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations — Running, not enrolling
• A Study of AGEN2034 in Advanced Tumors and Cervical Cancer — Completed
• A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults — Stopped early
• Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer — Completed
• Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer — Completed
• A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms — Completed
• Study of ORIC-101 in Combination With Anticancer Therapy — Stopped early
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene — Completed
• Study of INCB053914 in Subjects With Advanced Malignancies — Stopped early
• Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors — Completed